HELIX SCREENING
Hereditary Actionable Disorders Panel
Panel Description
Helix Hereditary Actionable Disorders Panel is a screening test that analyzes genes related to hereditary predisposition to oncology, cardiology, metabolic, muscular and blood clottting disorders. This test only reports clinically significant pathogenic and likely pathogenic variants, unlike diagnostic testing, which also reports variants of uncertain significance (VUS).
Genes Tested (69)
Scroll down for more
Important Test Information
Turnaround time: 3-6 weeks
Preferred specimen: BD Vacutainer Whole Blood K2 EDTA Collection Tube 4mL or Oragene Dx Saliva Collection Kit
Shipping Instructions: Specimens to arrive at Helix within 96 hours of collection at ambient temperature.
The Helix Hereditary Actionable Disorders Panel analyzes 69 genes related to hereditary predisposition to oncology, cardiology, metabolic, muscular and blood clottting disorders. This test only reports clinically significant pathogenic and likely pathogenic variants, unlike diagnostic testing, which also reports variants of uncertain significance (VUS).
All detected variants are evaluated according to American College of Medical Genetics and Genomics recommendations. Variants are classified based on known, predicted, or possible pathogenicity; however, this test only reports pathogenic and likely pathogenic variants along with interpretive comments detailing the evidence applied towards classification. Variants of uncertain significance are not reported.